Viral infections in immunocompromised patients: what's new with respiratory viruses?
about
Use of a novel cell-based fusion reporter assay to explore the host range of human respiratory syncytial virus F protein.A multicenter evaluation of pandemic influenza A/H1N1 in hematopoietic stem cell transplant recipients.Pandemic influenza and its implications for transplantation.Planning for pandemic influenza: effect of a pandemic on the supply and demand for blood products in the United States.Clinical and radiological features of respiratory syncytial virus in solid organ transplant recipients: a single-center experience.Perspective: emerging challenges in the treatment of influenza and parainfluenza in transplant patientsPositive selection results in frequent reversible amino acid replacements in the G protein gene of human respiratory syncytial virus.Residues in the heptad repeat a region of the fusion protein modulate the virulence of Sendai virus in miceDetection of E119V and E119I mutations in influenza A (H3N2) viruses isolated from an immunocompromised patient: challenges in diagnosis of oseltamivir resistance.Multiple, non-conserved, internal viral ligands naturally presented by HLA-B27 in human respiratory syncytial virus-infected cellsChanging attitudes toward influenza vaccination in U.S. Kidney transplant programs over the past decade.The quest for an efficacious antiviral for respiratory syncytial virus.Viral infection is not uncommon in adult patients with severe hospital-acquired pneumoniaPersistence of adenovirus nucleic acids in nasopharyngeal secretions: a diagnostic conundrum.First pharmacokinetic and safety study in humans of the novel lipid antiviral conjugate CMX001, a broad-spectrum oral drug active against double-stranded DNA viruses.Prospective study of the incidence, clinical features, and outcome of symptomatic upper and lower respiratory tract infections by respiratory viruses in adult recipients of hematopoietic stem cell transplants for hematologic malignanciesComparison of the Luminex xTAG RVP Fast assay and the Idaho Technology FilmArray RP assay for detection of respiratory viruses in pediatric patients at a cancer hospital.Viral respiratory tract infections in transplant patients: epidemiology, recognition and management.Immunizations and infectious diseases in pediatric liver transplantation.Diagnosis and treatment of viral diseases in recipients of allogeneic hematopoietic stem cell transplantation.Viral pneumonias in immunocompromised adult hosts.Long-term outcome after liver transplantation.The FilmArray® respiratory panel: an automated, broadly multiplexed molecular test for the rapid and accurate detection of respiratory pathogens.The viral transcription group determines the HLA class I cellular immune response against human respiratory syncytial virus.Unusual viral ligand with alternative interactions is presented by HLA-Cw4 in human respiratory syncytial virus-infected cells.Human metapneumovirus associated with respiratory tract infections in a 3-year study of nasal swabs from infants in Italy.[Fever, coughing and dyspnea in a 38-year-old female kidney transplant recipient].Contribution of cysteine residues in the extracellular domain of the F protein of human respiratory syncytial virus to its function.Comparison of the direct fluorescence assay and real-time polymerase chain reaction for the detection of influenza virus A and B in immunocompromised patients.Post-transplant Viral Respiratory Infections in the Older Patient: Epidemiology, Diagnosis, and Management.Randomized, double-blind comparison of standard-dose vs. high-dose trivalent inactivated influenza vaccine in pediatric solid organ transplant patients.Isolation and characterization of monoclonal antibodies which neutralize human metapneumovirus in vitro and in vivo.Significant morbidity associated with RSV infection in immunosuppressed children following liver transplantation: case report and discussion regarding need of routine prophylaxis.Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy.Respiratory syncytial virus lower respiratory tract infection in a pediatric liver transplant recipient treated with oral ribavirin.Human respiratory syncytial virus infects and induces activation markers in mouse B lymphocytes.Human metapneumovirus infections cause similar symptoms and clinical severity as respiratory syncytial virus infections.Comparison of the seroprevalence of human metapneumovirus and human respiratory syncytial virus.Human metapneumovirus infection after allogeneic hematopoietic stem cell transplantation.Molecular analysis of hemagglutinin, neuraminidase, matrix genes provide insight into the genetic diversity of seasonal H3N2 human influenza a viruses in Bangladesh during July-August, 2012.
P2860
Q24815873-02719C0E-35CF-4DE3-BF75-B867A1754DBFQ30352359-880DEDAD-0DC2-4455-AE65-C926219726A8Q30355400-655F8820-98B3-4032-9518-A5FE91E463A3Q30361932-656FC7AE-8486-4231-9E7D-8D9C1C49B8F7Q30409593-E39F6BD5-1B11-4036-B747-22B68E8679C6Q30412678-ECD6929A-40E5-4A1C-A84E-FAB1F7DDF43FQ33396977-68C1BBAB-E627-4D66-91BF-0231A6D32B68Q33558419-911EE03B-0CA2-415C-8A68-C2C165F8309AQ33826384-6135574F-E9CB-49DB-A298-59936E8412A4Q34122073-97AA18F4-5B23-4E6F-9DF2-4F12341A163CQ34281530-8C5DE002-960A-4581-8A4B-7C30C8D96E18Q35115949-186A1BE4-AA67-47D6-9599-DC58C4C2A177Q35154038-C84B415A-E889-4F2A-9B21-DA0F03C9AE49Q35503072-74A2C768-1872-403A-A947-FEC534FEB353Q35941261-0975D74D-0929-4C92-8306-4297F5B8D423Q35945742-AC001271-D84B-4887-AACB-8AF98A7F08EAQ36118576-F67B86CA-6609-4BC2-B4B6-485BBAD0BC26Q36864610-452505AA-902F-4259-8688-7B37B2B1F740Q37282595-F5AEBBDA-52DA-4DC6-BCFB-9ABD274A4E76Q37426542-714BC3D4-E27E-41A7-A809-B129CB3125BAQ37788451-D2157D05-CE89-4527-8579-7815F27B4CF7Q38002368-8D3A7CE2-F60F-48E5-9019-2FCE8AEB8030Q38154928-353995DD-AEF2-4EA3-A4CA-B32613B85C2BQ38915023-A68D11A7-66CD-4107-B677-F09BF39571AFQ39639898-1108BEAA-4C9B-467D-815A-C30A30F3B72EQ39789769-AF73AFB8-E5C6-413A-9473-0AD5ABD39A1EQ40270025-1EA0D570-0EEB-43D6-B6DF-2FF2D40FC786Q40275833-7895324D-A8F6-42EF-9BD6-A0DF4433B76FQ41778563-E248C493-0D69-4C7A-889F-D12F837B8AC1Q41927260-BA65CA00-7222-4054-B6CF-9D094BF3A501Q42176587-F79DAB37-FDE1-4121-9062-59975EEC1607Q42262149-F4640F7C-C8FA-49AC-B3EC-01E1238B24BFQ44081418-9C2378FB-D719-428F-9F1C-002883FF048BQ45115470-036673A7-9EA4-4236-B83B-F7820364B8FBQ45358049-FA3B9722-3986-4747-9A6E-94425C95289CQ45387210-AE233399-8B1F-498C-8782-9A1C59610BA7Q45417824-E826B302-56AD-41F8-A9DC-0865F1252332Q45702122-56E957E1-A185-4200-822B-4982ECFA46BCQ50551600-71366191-CF65-494B-8C77-0B40B7BE7D9FQ53699476-193C54DA-92A9-4C48-8375-48F884BB54AF
P2860
Viral infections in immunocompromised patients: what's new with respiratory viruses?
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Viral infections in immunocompromised patients: what's new with respiratory viruses?
@ast
Viral infections in immunocompromised patients: what's new with respiratory viruses?
@en
type
label
Viral infections in immunocompromised patients: what's new with respiratory viruses?
@ast
Viral infections in immunocompromised patients: what's new with respiratory viruses?
@en
prefLabel
Viral infections in immunocompromised patients: what's new with respiratory viruses?
@ast
Viral infections in immunocompromised patients: what's new with respiratory viruses?
@en
P1476
Viral infections in immunocompromised patients: what's new with respiratory viruses?
@en
P2093
Michael G Ison
P304
P356
10.1097/00001432-200208000-00002
P577
2002-08-01T00:00:00Z